Georg is Director of Business Development at Genmab where he is responsible for identifying, evaluating, and negotiating partnership agreements with other biotech companies and academic institutes. Georg has been active in the Biotech industry for more than 10 years and has played in instrumental role in a variety of Genmab's current partnerships, from exploratory research agreements to broad multi-product strategic collaborations. Prior to joining Genmab in 2018, Georg has worked in a variety of roles spanning the areas of R&D, Competitive Intelligence, Corporate Finance and Business Development at companies such as Synthon, arGEN-X, Corbion and Kempen & Co. He has a scientific background in Molecular Biology & Microbiology and graduated with a MSc degree in Science & Business Management from the University of Utrecht.